Drug testing on arrest-who benefits?
Drug testing
Drug treatment
Offender management
Strategic commissioning
Systems
UK
Journal
Health & justice
ISSN: 2194-7899
Titre abrégé: Health Justice
Pays: England
ID NLM: 101626355
Informations de publication
Date de publication:
16 Jan 2020
16 Jan 2020
Historique:
received:
11
06
2019
accepted:
27
12
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
18
1
2020
Statut:
epublish
Résumé
Drugs and crime are linked and diversion from the criminal justice system into drug treatment is a well-established policy response. The point of arrest is a pivotal moment to initiate a drug-specific intervention. This paper assesses the impact of the introduction of drug testing on arrest (DToA) into a low crime area in England. Our mixed methods study analysed performance data collected by the National Drug Treatment Monitoring/Drug Test Recorder datasets and feedback from a series of semi-structured interviews with both clients and professionals. In total, 2210 people were tested 2861 times of which 42.0% (n = 928) tested positive. Of those, 3% subsequently engaged with effective treatment. However, throughout the criminal justice system, treatment engagements increased year on year from 20% (n = 77) to 26% (n = 131). Clients (n = 19) and professionals (n = 14) reported that DToA was an acceptable/tolerable addition to the treatment pathway. Interviews suggested that the point of arrest may help primary desistance from further offending. The staggered introduction of the DToA made direct measure of impact difficult and there appears to have been a 'displacement' effect in response to the extra investment. However, DToA appears to have contributed towards an overall uplift in criminal justice drug treatment system performance activities (identification, assessment, referral etc.) and may have served to help strengthen care pathways. Barriers were noted about engagement with DToA by entrenched opiate users, suggesting that the effectiveness of DToA was limited within that group. This study is the first to investigate the impact of the introduction of DToA into a low crime area.
Sections du résumé
BACKGROUND
BACKGROUND
Drugs and crime are linked and diversion from the criminal justice system into drug treatment is a well-established policy response. The point of arrest is a pivotal moment to initiate a drug-specific intervention. This paper assesses the impact of the introduction of drug testing on arrest (DToA) into a low crime area in England. Our mixed methods study analysed performance data collected by the National Drug Treatment Monitoring/Drug Test Recorder datasets and feedback from a series of semi-structured interviews with both clients and professionals.
RESULTS
RESULTS
In total, 2210 people were tested 2861 times of which 42.0% (n = 928) tested positive. Of those, 3% subsequently engaged with effective treatment. However, throughout the criminal justice system, treatment engagements increased year on year from 20% (n = 77) to 26% (n = 131). Clients (n = 19) and professionals (n = 14) reported that DToA was an acceptable/tolerable addition to the treatment pathway. Interviews suggested that the point of arrest may help primary desistance from further offending.
CONCLUSIONS
CONCLUSIONS
The staggered introduction of the DToA made direct measure of impact difficult and there appears to have been a 'displacement' effect in response to the extra investment. However, DToA appears to have contributed towards an overall uplift in criminal justice drug treatment system performance activities (identification, assessment, referral etc.) and may have served to help strengthen care pathways. Barriers were noted about engagement with DToA by entrenched opiate users, suggesting that the effectiveness of DToA was limited within that group. This study is the first to investigate the impact of the introduction of DToA into a low crime area.
Identifiants
pubmed: 31950292
doi: 10.1186/s40352-019-0103-z
pii: 10.1186/s40352-019-0103-z
pmc: PMC6966786
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3Références
Health Technol Assess. 2015 Jan;19(6):1-168, vii-viii
pubmed: 25619533
Drug Alcohol Depend. 2000 Nov 1;60(3):275-86
pubmed: 11053762
Psychiatr Serv. 2001 Sep;52(9):1223-9
pubmed: 11533397
Addiction. 2009 Feb;104(2):243-7
pubmed: 19149820
Drug Alcohol Depend. 2005 Sep 1;79(3):295-302
pubmed: 16102373
J Addict Dis. 2017 Jan-Mar;36(1):5-13
pubmed: 27135713
Addiction. 2005 Mar;100(3):304-16
pubmed: 15733244
Int J Drug Policy. 2000 Aug;11(4):259-64
pubmed: 10930788
Psicothema. 2006 Aug;18(3):620-9
pubmed: 17296096